Hemostemix Stock Profit Margin
HEM Stock | CAD 0.07 0.01 7.14% |
Hemostemix fundamentals help investors to digest information that contributes to Hemostemix's financial success or failures. It also enables traders to predict the movement of Hemostemix Stock. The fundamental analysis module provides a way to measure Hemostemix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Hemostemix stock.
Last Reported | Projected for Next Year |
Hemostemix | Profit Margin |
Hemostemix Company Profit Margin Analysis
Hemostemix's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Hemostemix Profit Margin Driver Correlations
Understanding the fundamental principles of building solid financial models for Hemostemix is extremely important. It helps to project a fair market value of Hemostemix Stock properly, considering its historical fundamentals such as Profit Margin. Since Hemostemix's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Hemostemix's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Hemostemix's interrelated accounts and indicators.
Click cells to compare fundamentals
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Competition |
Based on the latest financial disclosure, Hemostemix has a Profit Margin of 0.0%. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The profit margin for all Canada stocks is 100.0% lower than that of the firm.
Did you try this?
Run Watchlist Optimization Now
Watchlist OptimizationOptimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm |
All Next | Launch Module |
Hemostemix Fundamentals
Return On Asset | -3.49 | ||||
Current Valuation | 14.56 M | ||||
Shares Outstanding | 140.64 M | ||||
Shares Owned By Insiders | 9.54 % | ||||
Number Of Shares Shorted | 11.93 K | ||||
Price To Earning | (1.70) X | ||||
Price To Book | 27.76 X | ||||
EBITDA | (2.16 M) | ||||
Net Income | (2.5 M) | ||||
Cash And Equivalents | 49.36 K | ||||
Total Debt | 4.32 M | ||||
Current Ratio | 0.05 X | ||||
Book Value Per Share | (0.09) X | ||||
Cash Flow From Operations | (1.5 M) | ||||
Short Ratio | 0.17 X | ||||
Earnings Per Share | (0.03) X | ||||
Target Price | 0.96 | ||||
Beta | 0.19 | ||||
Market Capitalization | 10.55 M | ||||
Total Asset | 313.76 K | ||||
Retained Earnings | (63.27 M) | ||||
Working Capital | (2.56 M) | ||||
Net Asset | 313.76 K |
About Hemostemix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Hemostemix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Hemostemix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Hemostemix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Hemostemix Stock Analysis
When running Hemostemix's price analysis, check to measure Hemostemix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hemostemix is operating at the current time. Most of Hemostemix's value examination focuses on studying past and present price action to predict the probability of Hemostemix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hemostemix's price. Additionally, you may evaluate how the addition of Hemostemix to your portfolios can decrease your overall portfolio volatility.